TR200102024T2 - Yeni tedavi. - Google Patents

Yeni tedavi.

Info

Publication number
TR200102024T2
TR200102024T2 TR2001/02024T TR200102024T TR200102024T2 TR 200102024 T2 TR200102024 T2 TR 200102024T2 TR 2001/02024 T TR2001/02024 T TR 2001/02024T TR 200102024 T TR200102024 T TR 200102024T TR 200102024 T2 TR200102024 T2 TR 200102024T2
Authority
TR
Turkey
Prior art keywords
hepatitis
virus
new treatment
antiviral agent
infection
Prior art date
Application number
TR2001/02024T
Other languages
English (en)
Inventor
Frances Atkinson Gillian
James Boon Ronald
G. Vandepapeliere Pierre
Anne Cecile Wettendorff Martine
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200102024T2 publication Critical patent/TR200102024T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus hepatit B enfeksiyonunun önlenmesi ve/ya da tedavi edilmesi için, aktif maddeler olarak (1) hepatit B virüsüne karsi aktif olan antiviral bir ajani ve (2) bir asiyi içeren farmasötik bir paket saglar, aktif maddeler es zamanli ya da sirasiyla kullanilmaktadirlar. Tercih edilen maddeler bir hepatit B virüsü yüzey antijenini içeren bir hepatit B virüsü asisiyla birlikte antiviral ajan olarak bir nükleosit benzeridir.
TR2001/02024T 1999-01-12 1999-12-21 Yeni tedavi. TR200102024T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12

Publications (1)

Publication Number Publication Date
TR200102024T2 true TR200102024T2 (tr) 2001-12-21

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02024T TR200102024T2 (tr) 1999-01-12 1999-12-21 Yeni tedavi.

Country Status (19)

Country Link
EP (1) EP1140163A2 (tr)
JP (1) JP2002534438A (tr)
KR (1) KR20010090011A (tr)
CN (1) CN1391482A (tr)
AR (1) AR022250A1 (tr)
AU (1) AU760574B2 (tr)
BR (1) BR9916893A (tr)
CA (1) CA2359110A1 (tr)
CO (1) CO5241355A1 (tr)
CZ (1) CZ20012544A3 (tr)
HK (1) HK1041434A1 (tr)
HU (1) HUP0105070A2 (tr)
IL (1) IL144186A0 (tr)
NO (1) NO20013337L (tr)
NZ (1) NZ512890A (tr)
PL (1) PL349347A1 (tr)
TR (1) TR200102024T2 (tr)
WO (1) WO2000041463A2 (tr)
ZA (1) ZA200105690B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077722B1 (en) 1998-05-22 2006-08-09 Ottawa Health Research Institute Methods and products for inducing mucosal immunity
KR100767554B1 (ko) 1998-07-31 2007-10-17 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 암 억제 유전자 더블유티1의 생산물에 기초한 암항원
EP1371664B1 (en) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti modified peptide
JPWO2003028758A1 (ja) * 2001-09-28 2005-01-13 治夫 杉山 抗原特異的t細胞の誘導方法
EP1447091A4 (en) * 2001-09-28 2008-02-13 Institute Of Can International NEW METHOD FOR INDUCTION OF ANTIGEN SPECIFIC T CELLS
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
JP2006515277A (ja) 2002-10-29 2006-05-25 コーリー ファーマシューティカル グループ, リミテッド C型肝炎ウィルス感染の処置および予防に関する方法および製品
JP2006512927A (ja) 2002-12-11 2006-04-20 コーリー ファーマシューティカル グループ,インコーポレイテッド 5’cpg核酸およびその使用方法
CN100443117C (zh) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途
WO2005121378A2 (en) * 2004-06-03 2005-12-22 Saint Louis University Methods and compositions for vaccination
AR065504A1 (es) * 2007-02-28 2009-06-10 Ct Ingenieria Genetica Biotech Terapia combinada para el tratamiento de la hepatitis b cronica. uso.
US20220088188A1 (en) * 2018-12-24 2022-03-24 Grand Theravac Life Science (Nanjing) Co., Ltd. Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof
JPWO2022215737A1 (tr) * 2021-04-07 2022-10-13

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0414374T3 (da) * 1989-07-25 1998-03-09 Smithkline Beecham Biolog Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf
HUP0101047A3 (en) * 1998-03-09 2004-10-28 Smithkline Beecham Biolog Combined vaccine compositions

Also Published As

Publication number Publication date
NO20013337L (no) 2001-08-17
EP1140163A2 (en) 2001-10-10
AU2100900A (en) 2000-08-01
NZ512890A (en) 2003-09-26
CZ20012544A3 (cs) 2002-01-16
JP2002534438A (ja) 2002-10-15
HUP0105070A2 (hu) 2002-04-29
PL349347A1 (en) 2002-07-15
ZA200105690B (en) 2002-09-25
BR9916893A (pt) 2001-11-20
AU760574B2 (en) 2003-05-15
AR022250A1 (es) 2002-09-04
WO2000041463A3 (en) 2000-11-09
HK1041434A1 (zh) 2002-07-12
CN1391482A (zh) 2003-01-15
KR20010090011A (ko) 2001-10-17
CA2359110A1 (en) 2000-07-20
CO5241355A1 (es) 2003-01-31
IL144186A0 (en) 2002-05-23
NO20013337D0 (no) 2001-07-05
WO2000041463A2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
NO20025627D0 (no) Fremgangsmåter og sammensetninger for å behandle hepatitt C virus
TR200102024T2 (tr) Yeni tedavi.
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
TR200200938T2 (tr) CCR5 modülatörleri olarak piperidinler
DE69230140D1 (de) Antivirale nucleosidkombination
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
BR9808100A (pt) Utilização de amandantina para tratamento de hepatite c.
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
ATE245444T1 (de) Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
DK1140113T3 (da) Anvendelse af bisphosphonater til profylakse og behandling af infektiøse processer
DE69933671D1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE253938T1 (de) Pharmazeutische kombination von antiviralen wirkstoffen
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény